Literature DB >> 9044386

Morphine modulation of GABA- and glutamate-induced changes of ventral pallidal neuronal activity.

P I Johnson1, T C Napier.   

Abstract

Microiontophoresis was used to investigate the influence of morphine on the GABA- and glutamate-evoked responses of ventral pallidal neurons recorded extracellularly from chloral hydrate-anesthetized rats. Of the GABA-sensitive neurons (50 of 69 tested) in the ventral pallidum, all displayed a decreased firing rate when GABA was applied, whereas all of the glutamate-sensitive neurons (29 of 40 tested) increased neuronal activity in the presence of glutamate. The majority of ventral pallidal cells tested (65 of 83) were sensitive to iontophoretically applied morphine, and both increases and decreases in neuronal activity were observed. The ability of morphine to alter the ratio between amino acid-evoked activity ("signal") and spontaneous firing ("noise") was used as an indicator of morphine modulation. A morphine subthreshold ejection current, i.e. one that did not change spontaneous firing rate, and a morphine ejection current that produced approximately 50% of the maximum opioid-induced neuronal response were chosen for this evaluation. When morphine was co-iontophoresed with GABA or glutamate, attenuation of the amino acid signal-to-noise ratio was generally seen, though some potentiations were observed. These changes were independent of the direction of morphine-induced changes in spontaneous firing rate. Both sub- and suprathreshold ejection currents were capable of affecting GABA- and glutamate-evoked responses. These data suggest that morphine is a robust ventral pallidal neuromodulator. As ventral pallidal amino acid activity is important in the integration of sensorimotor information, opioid modulation of amino acid transmission in the ventral pallidum may have a profound effect on this integration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9044386     DOI: 10.1016/s0306-4522(96)00482-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior.

Authors:  K McFarland; P W Kalivas
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

Review 2.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

3.  Changes in accumbal and pallidal pCREB and deltaFosB in morphine-sensitized rats: correlations with receptor-evoked electrophysiological measures in the ventral pallidum.

Authors:  John McDaid; Jeanine E Dallimore; Alexander R Mackie; T Celeste Napier
Journal:  Neuropsychopharmacology       Date:  2006-06       Impact factor: 7.853

4.  Presynaptic versus postsynaptic localization of mu and delta opioid receptors in dorsal and ventral striatopallidal pathways.

Authors:  M F Olive; B Anton; P Micevych; C J Evans; N T Maidment
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

5.  mu-opioid receptor-mediated antinociceptive responses differ in men and women.

Authors:  Jon-Kar Zubieta; Yolanda R Smith; Joshua A Bueller; Yanjun Xu; Michael R Kilbourn; Douglas M Jewett; Charles R Meyer; Robert A Koeppe; Christian S Stohler
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

6.  Ventral pallidal representation of pavlovian cues and reward: population and rate codes.

Authors:  Amy J Tindell; Kent C Berridge; J Wayne Aldridge
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

Review 7.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

Review 8.  Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation.

Authors:  Alexei Korchounov; Michael F Meyer; Michael Krasnianski
Journal:  J Neural Transm (Vienna)       Date:  2010-11-16       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.